CLINICAL_TRIALS
trial_result
· 2016-04-18
Clinical Trial Update: Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag [Phase 2]
Summary
Phase 2 trial evaluating safety and efficacy of eltrombopag in solid tumor patients with thrombocytopenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Thrombocytopaenia | Phase 2 | Status: COMPLETED | Results posted: 2016-04-18